$
Federal Contract Award
Mapp Biopharmaceutical, INC.
Department of Defense · September 16, 2025 · FY2025
HT942525FE048Set-aside not reportedNAICS 325413
Obligated
$60,500
Contract details
- Award ID
- CONT_AWD_HT942525FE048_9700_HT942525D0009_9700
- PIID
- HT942525FE048
- Period of performance
- September 19, 2025 → February 25, 2026
- Place of performance
- SAN DIEGO, CA, USA
- Set-aside
- Not reported
- Pricing type
- FIRM FIXED PRICE
- PSC
- 6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- NAICS
- 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Scope
HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS
Parent vehicle (IDV)
Mapp Biopharmaceutical, INC.
UEI M9V9QTHR1H28
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Mapp Biopharmaceutical, INC. →- UEI
- M9V9QTHR1H28
- CAGE
- 417U0
- Parent
- Mapp Biopharmaceutical, INC.
- Address
- SAN DIEGO, CA
Awarding agency
Department of Defense →- Sub-agency
- Defense Health Agency
- Office
- ARMY MED RES ACQ ACTIVITY
- Funding agency
- Department of Defense
- Funding office
- ARMY MED RES INST OF DESEASE - PB
See every contract Mapp Biopharmaceutical, INC. has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Mapp Biopharmaceutical, INC. profile →